Close Menu

University of Ottawa

LiveScience writes that a recent analysis implicating dogs as the source of SARS-CoV-2 may not be convincing.

The money is being provided under three Genome Canada funding competitions in partnership with the Canadian federal government and other groups.

In PNAS this week: rise of copy-number variants during neurogenesis, genetic and phenotypic variation in Pseudomonas aeruginosa, and more.

New tumor profiling papers stemming from prior clinical trials led to informative mutations in early-stage, ER+/HER2- breast cancer and lung squamous cell carcinoma.

The initiatives are being funded with C$24 million over two years and will focus on acute leukemia, immuno-oncology, and brain, ovarian, and pancreatic cancer.

In PLOS this week: common variants linked to neuroblastoma susceptibility, rabies virus phylogeography, and more.

The researchers will use genomics to address challenges facing Canada's forestry, healthcare, agricultural, and aquacultural industries.

Using mass spectrometry, the scientists found protein panels that could separate IBD patient biopsies from controls and UC from CD, respectively.

University of Ottawa researchers have developed an electrical method for fabricating solid-state nanopores based on a phenomenon called dielectric breakdown — an approach that they are touting as fast, affordable, and easily applicable within the context of existing solid-state d

NEW YORK (GenomeWeb News) – The government of Ontario recently announced about C$7 million (US$6.7 million) in new funding for four large-scale genomics projects.

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.